Position paper
27 Oct 2025
Policy considerations for the development, regulation and adoption of biosimilars
Biosimilars can play a role in expanding patient access to biological medicines and in supporting the sustainability of healthcare systems. To fully realize this potential, IFPMA recommends the adoption of a series of policy recommendations.
Read more
Statement
21 Oct 2025
76th Session of the WHO Regional Committee for the Western Pacific on “Implementing the International Health Regulations (2005) amendments”
On 21 October 2025 in Nadi, Fiji, IFPMA delivered a statement at the 76th Session of the WHO Regional Committee for the Western Pacific on “Implementing the International Health Regulations (2005) amendments.” We commend the Western Pacific Region for its engagement to develop priority actions for countries and areas in the region to utilize the...
Read more
Statement
14 Oct 2025
78th Session of the WHO Regional Committee for South-East Asia on primary health care and universal health coverage
On 14 October 2025 in Colombo, Sri Lanka, IFPMA delivered a statement on primary health care (PHC) and universal health coverage (UHC) at the 78th Session of the WHO Regional Committee for South-East Asia. IFPMA welcomes the agenda items on PHC and UHC. Unlocking investment in primary care is critical if we are to build...
Read more